Académique Documents
Professionnel Documents
Culture Documents
Estrogen
Accelerated bone maturation and early
epiphyseal fusion (tall child but short
adult)
Uterus, mammary gland
Testosterone
Genital, Hirsutism, acne, male habitus
General:sexual behavior, aggressiveness
Classification
GnRH dependent (central) :
premature reactivation hypothalamus-pituitary-
gonad axis increased gonadotropin increased
sex steroids (dependent)
Usually idiopathic
GnRH independent (peripheral):
autonomous sex steroid secretion, depressing
the hypothalamus-pituitary-gonad axis
Usually pathologic
Classification
Variant
premature thelarche
premature adrenarche
gynecomastia
Etiology GDPP
idiopathic
CNS
tumor
non-tumor: post infection, radiation,
trauma, congenital
iatrogenic
Delayed diagnosis of GIPP
Clinical manifestation GDPP
Always isosexual
Normal sequence of puberty
Hormonal profile: increased
gonadotropin and sex steroid
Etiology GIPP - male
Isosexual
adrenal: tumor, CAH
testes : cell Leydig tumor, familial
testotoxicosis
gonadotropin-secreting tumor:
non CNS: hepatoma, germinoma, teratoma
CNS: germinoma, adenoma (LH secreting)
heterosexual
Increased peripheral aromatization
Etiology GIPP - female
Isosexual)
McCune Albright
Severe
hypothyroid
heterosexual
adrenal: tumor,
CAH
tumor ovarium:
arrhenoblastoma
Mc Cune Albright Syndrome
Trias
Precocious puberty /
endocrine
hyperactivity
Fibrodysplasia
Caf au lait
Clinical manifestation GIPP
Isosexual or heterosexual (late onset
CAH, tumor adrenal)
Disconcordant of sexual characteristics
(testes volume inappropriate with pubertal
stage - smaller)
Low or normal gonadotropin and
increased sex steroid
Benign Premature Adrenarche
self-limited condition occurring before six
years of age
characterized by the appearance of pubic
and no further secondary sexual
development.
normal growth patterns
Benign Premature Adrenarche
Normal bone age
Slight elevation of serum DHEA
Normal adrenal steroid hormone levels
Normal sex hormone levels
ACTH stimulation test: to exclude late-
onset CAH
GnRH test: prepubertal pattern
Normal imaging studies
No specific treatment required
Premature Adrenarche
Excude virilization
clitoral enlargement, advanced bone
age, acne, rapid growth, and voice
change.
rapid progression
If virilization present
measure testosterone, 17-OHP and
DHEA
USG: adrenal or ovarian tumor
17-OHP or DHEA: CAH
Benign Premature Thelarche
Isolated appearance of unilateral or
bilateral breast aged 6 months to 3 years
No other signs of puberty or evidence of
excessive estrogen effect (thickening of
the vaginal secretions or bone age
acceleration).
Ingestion or application of estrogen-
containing compounds must be excluded
as etiology
Benign Premature Thelarche
Normal growth rate and bone age
Normal levels of gonadotropins and
estradiol
USG: normal ovaries, prepubertal uterus
Usually resolves spontaneously and
requires no treatment
re-evaluation at intervals of 6-12 months to
ensure that premaure thelarche is not the
beginning of isosexual precocious puberty
Gynecomastia
Breast enlargement in males
common in teenage years, lasting 2 years
differentiate with obese boys
lipomastia
no mammae disk
Pathological causes must be sought
Pubertal Gynecomastia
Incidence: 50-60% of boys during early
adolescence
breast tissue usually asymmetric and often
tender.
If history and physical examination,
including palpation of the testicles, are
unremarkable, reassurance and periodic
reevaluation are all that is necessary. Most
cases resolve in one to two years.
Gynecomastia
Drugs
sex steroids, hCG,
psychoactive (phenotiazine),
antituberculosis,
testosterone antagonist
(ketoconazole, cimetidine,
spironolactone)
Malnutrition
Idiopathic (most common)
Tumor producing disease
hepatoma, adrenal, testes, LH
and hCG producing tumors
Pubertal Gynecomastia
Familial gynecomastia
X-linked recessive trait or a sex-limited
dominant trait
unless associated with hypogonadism no
further evaluation in an otherwise normal boy
If severe, gynecomastia cosmetic surgery.
Pathologic gynecomastia
Klinefelter's syndrome: high risk for breast
cancer
prolactin-secreting adenomata
Pubertal Gynecomastia
Pathologic gynecomastia
hormone-secreting tumors (testes,
hepatoma), cirrhosis, hypo- and
hyperthyroidism.
Drug induced (marijuana, phenothiazines,
opiates, amphetamines, digitalis, estrogens,
ketoconazole, spironolactone, isoniazid,
tricyclic antidepressants, cimetidine, etc).
If worsens and associated with psychologic
morbidity bromocriptine, tamoxifen
reduction mammoplasty rarely indicated.
Diagnostic work up
Gonadotropin dependent or independent?
Etiology?
Hypothalamus
GnRH
(-) Pituitary
LH/FSH
Gonad
E2 or T
H-P-G axis
Hypothalamus
GnRH
Primary
(-) Pituitary
LH/FSH
Gonad
Sex steroid
H-P-G axis in GDPP
Hypothalamus
GnRH
(-) Pituitary
LH/FSH
Gonad
Extra Gonadal
Sex steroid
Hipotalamus LHRH
Hipofisis LH/FSH
(-)
Target Organ Primary defect
(gonad)
Sex Steroid
Hipergonadotropik hipogonadism
Hipotalamus LHRH
Primary defect
Hipofisis LH/FSH
(-)
Target Organ
(gonad)
Sex Steroid
Hipogonadotropik hipogonadism
Constitutional delay
Kelainan Susunan Syaraf Pusat
Tumor (craniopharyngioma, germinoma,
optic glioma, histiocytosis X)
Struktural (mid line defect)
Sindrom Kallmann
hipopituitarism idiopathic
pasca tindakan (radiasi, khemoterapi
inflamasi, infiltrasi - hemosiderosis)
Hipogonadotropik hipogonadism
Penyakit kronis
endokrin, malnutrisi/anorexia nervosa,
kelainan sistemik
Aktivitas fisik berlebihan
Sindrom-sindrom
Prader-Willi; Laurence-Moon-Biedl
Hypothalamic and pituitary causes of
pubertal failure-low gonadotrophins
Congenital defects
Kalmann syndrome
Congenital adrenal hypoplasia
Septoptic dysplasia
Development defect of pituitary
Tumors, direct effects or following
radiotherapy or surgery
Haemochromatosis
Thalassemia and endocrinopathy. A
multicenter study (N=3092)
7%
4% 3%
6%
80%
YES NO
Check
Psychological distress?
height, FSH/LH, T4/TSH,
Prolactin, Karyotype (girls)
NO YES
oxandrolone /
sex steroids
GnRh /
sex steroids sex steroids
Female patients
chronological age > 13-14 years
bone age > 11 years
Male patients
chronological age > 14-15 years
bone age > 12 years
Hormonal replacement
Females :
start estrogen 0,25 mg daily (6-9
months)
after 9 MOs cyclic therapy estrogen
for 1st 21 days
Males:
testosterone enanthate 50 mg IM/
monthly
after 6-9 MOs, dose gradually increased
to 200 mg/3 weeks (2-3 years)
KESIMPULAN
Pubertas berlangsung menurut stadium,
umur tertentu
Pubertas harus selalu menjadi perhatian
orangtua / tenaga kesehatan
Setiap tenaga kesehatan dapat
mendeteksi kelainan pubertas secara
dini dan segera melakukan rujukan